BioHealth News Archive
Opinion | Sputnik set off the Space Age. This virus can spark the Health Age. – The Washington Post
Regina E. Dugan is chief executive of Wellcome Leap, a nonprofit that seeks breakthroughs in human health. From 2009 to 2012, she served as…
Read MoreHopkins spinoff Thrive Earlier Detection Corp. raises $257 million funding round – Baltimore Business Journal
Johns Hopkins cancer diagnostics spinoff Thrive Earlier Detection Corp. has raised $257 million in new funding a little over a year after it closed…
Read MoreAmerican Gene Technologies (AGT) Moves HQ to New Facility, Expands Lab Space for HIV and Cancer Cure Research – Across From National Cancer Institute Campus | American Gene Technology
ROCKVILLE, Md., July 28, 2020 -- American Gene Technologies (AGT), an internationally recognized leading gene and cell therapy company in Rockville, Maryland, today announced…
Read MoreSARS-CoV-2 Lurked for Decades Where Others Like It Lurk Still
Future pandemics—and suffering of the kind inflicted by COVID-19—could be avoided if we troubled ourselves to see where dangerous pathogens lie in wait. We…
Read MoreBiotechnology draws $12.6B from private equity, venture capital activity in H1 | S&P Global Market Intelligence
Biotechnology led the healthcare industry in investment activity from private equity and venture capital during the first half of 2020, drawing nearly $12.60 billion…
Read MoreJohns Hopkins Receives $35M In Funding For COVID-19 Blood Plasma Trials – CBS Baltimore
BALTIMORE (WJZ) — Johns Hopkins researchers have received over $30 million in funding from the U.S. Department of Defense for two nationwide clinical trials to…
Read MoreInnate Pharma announces publication of EXPLORE COVID-19 translational study findings in Nature | Innate Pharma
Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the publication of a Nature paper entitled,…
Read MoreIllumina Accelerator Grant Competition
Now Accepting Rolling Grant Applications The Illumina Accelerator Sequencing Grant Competition encourages entrepreneurs to build startups using next-generation sequencing. Awarded grant winners have the…
Read MoreSHYCOCAN – A Device to Disable Coronaviruses – to be Marketed Under US-FDA’s Enforcement Discretion During the COVID-19 Public Health Emergency | BioSpace
GAITHERSBURG, Md., July 23, 2020 /PRNewswire/ -- Shreis Scalene Therapeutics LLC (SSTx), a MD-USA-based medical device company will fast-track the manufacture and distribution of…
Read MoreTruGenomix just won Start Up of the Year Pitch Event
Excited to announce that TruGenomix just won Start Up of the Year Pitch Event. Great pitch Charles Cathlin !!!!! #SDVOB #ptsd #TruGenomix #veteranshelpingveterans
Read MoreEmergent Bio inks deal with AstraZeneca for manufacture of COVID-19 vaccine (NYSE:EBS) | Seeking Alpha
Emergent BioSolutions (NYSE:EBS) has signed an agreement with AstraZeneca (NYSE:AZN) to provide contract development and manufacturing (CDMO) services for large-scale drug substance manufacturing for AZN's…
Read MoreUndergraduate Scholarships
Each scholarship is a one-time award; however previous applicants and past scholarship recipients are eligible to re-apply. Full-time, part-time, online and distance learning programs…
Read MoreAstraZeneca mines another $6B ADC from Daiichi Sankyo, with blockbuster ambitions to ‘redefine treatment standards’ – Endpoints News
Pascal Soriot isn’t letting the all-consuming R&D and manufacturing work on a Covid-19 vaccine slow down his hunt for AstraZeneca’s next blockbuster cancer drugs.…
Read MoreEmergent BioSolutions Signs Agreement with AstraZeneca to Expand Manufacturing for COVID-19 Vaccine Candidate NYSE:EBS
GAITHERSBURG, Md., July 27, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed an agreement to provide contract development…
Read More“COVID-19 edition” of pediatric medical device
WASHINGTON – (July 22, 2020) – The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) announces eight winners chosen in its special COVID-19 edition…
Read More